Skip to content
Drug Policy Watch™
LatestTracking drug policy in all 50 states and Congress, updated every morning.See all ›
Drug Policy Watch · State Brief 2026

South Carolina

Snapshot (structured)

Adult-use cannabis
Illegal. No legalization framework; possession of one ounce or less remains a criminal misdemeanor.
Medical cannabis
Not legal. The Compassionate Care Act (S. 53) has passed the Senate in prior sessions but has never cleared the House; it stalled again in the 2025-2026 session.
Home grow
Prohibited (no legal cannabis program exists; the proposed medical bill would also ban home cultivation).
Intoxicating hemp / hemp THC
Sold widely under the 2018 federal loophole; lawmakers spent the 2026 session trying to ban or tightly restrict it. The Senate passed an amended bill (H. 4759) on March 20, 2026, but the House did not concur before sine die, so H. 4759 failed and intoxicating hemp remains legal and broadly available to adults.
Psychedelics
Illegal. All psilocybin, LSD, DMT and similar substances are Schedule I. No therapeutic-access or decriminalization bills identified for 2026.
Broad decriminalization
No. Multiple decriminalization bills filed (H. 3110, H. 3804, H. 3018) but none received a committee hearing in 2025 or 2026.
Harm reduction
Partial. Naloxone is broadly available via standing order; fentanyl test strips are distributed in practice; syringe services programs are not clearly authorized in statute (a legalization bill, S. 255, remains pending).
Governor (party)
Henry McMaster (Republican).
Legislature control
Republican veto-proof supermajority in both chambers (Senate roughly 34-12, House roughly 88-36); Republican trifecta.
Citizen ballot initiatives allowed
No. South Carolina has no statewide citizen initiative or referendum process.
Enclosure pressure score
5/5

Cannabis

South Carolina has no adult-use (recreational) cannabis program and no operational medical cannabis program. It remains one of the most restrictive states in the country on cannabis. Possession of one ounce (28 grams) or less of marijuana is a criminal misdemeanor.

The central medical-cannabis vehicle is the Compassionate Care Act, S. 53, sponsored by Republican Senator Tom Davis of Beaufort. It was prefiled in December 2024 and referred to the Senate Committee on Medical Affairs in January 2025 (SC Legislature, S. 53). The bill would let physician-certified patients with qualifying debilitating conditions buy up to a 14-day supply of infused and extracted products (no smoking; vaporization allowed) from licensed therapeutic cannabis pharmacies, with home cultivation prohibited (Vicente LLP). The 2025-2026 version strips the tax language that triggered a constitutional defeat of the 2022 bill in the House (Cannabis Business Times; Beard Bros Pharms).

Davis has repeatedly moved versions through the Senate, but the House has refused to take it up. In the 2025-2026 session the bill again failed to advance out of committee and did not reach a House floor vote before the regular session adjourned sine die on May 14, 2026 (SC Daily Gazette session recap; status per SC Legislature, S. 53). Because 2026 was the second year of the two-year 126th General Assembly, bills that did not pass die at sine die and must be refiled in the new General Assembly that convenes in January 2027.

Proposed market structure under S. 53 (if it ever passed): a limited license framework reported as roughly 15 cultivation centers, 30 processing facilities, and up to three pharmacies per county, overseen by the Department of Public Health and the Board of Pharmacy, with local governments able to restrict operations (Vicente LLP). These figures are from secondary analysis and should be confirmed against the enrolled bill text before use.

Key 2026 cannabis action: none enacted. The defining cannabis-adjacent fight of the session was over intoxicating hemp (see Hemp), not the plant itself.

Hemp

Intoxicating hemp-derived THC products (delta-8, delta-9 at low concentration, HHC, THC beverages, gummies, vapes) are currently sold widely across South Carolina in gas stations, vape shops and CBD stores, having proliferated under the 2018 federal farm bill loophole. Marijuana itself remains illegal, which made the hemp-THC market a politically charged anomaly (SC Daily Gazette, March 20, 2026).

The 2026 session featured a sustained legislative effort to rein this in, splitting Republicans between an outright ban camp and a regulate-and-tax camp. The lead vehicle, H. 4759 ("Intoxicating Hemp Beverages"), was prefiled December 16, 2025 by Rep. Weston Newton and roughly 40 other Republicans, introduced January 13, 2026, and reported favorably with amendment from House Judiciary on January 29, 2026 before being amended and recommitted to Judiciary on February 4, 2026 (SC Legislature, H. 4759; Marijuana Herald). The bill declares that manufacture, sale and distribution of consumable hemp products is strictly prohibited unless specifically allowed, bans online and direct-to-consumer shipment, vests enforcement in SLED (State Law Enforcement Division), and creates an alcohol-style licensing and tax regime for hemp beverages administered by the Department of Revenue (H. 4759 text).

On March 20, 2026 the Senate passed an amended version 35-4 after a two-week fight that included a past-midnight rejection and a do-over vote (SC Daily Gazette). As amended in the Senate: only liquor stores could sell hemp beverages and gummies up to 10 mg THC per serving; other stores (gas stations, grocery, vape shops) could sell only 12-ounce beverages capped at 5 mg THC, kept behind the counter; sales to anyone under 21 would carry up to two years in prison and a $5,000 fine on a first offense; a 5 ng/mL blood-THC driving threshold was added. A full-ban amendment failed 18-22 the prior week, and an effort to let restaurants serve the beverages also failed (SC Daily Gazette).

The amended bill then had to return to the House for concurrence, since the House had passed a simpler version. The House did not concur before the regular session adjourned sine die on May 14, 2026, so H. 4759 failed and intoxicating hemp THC products remain legal for adults in South Carolina (Charleston City Paper; see the live bill history at SC Legislature, H. 4759).

Federal exposure and the November 12, 2026 deadline: A last-minute provision in the November 2025 federal stopgap spending law (which ended the government shutdown) is set to redefine legal hemp so that products could contain no more than 0.4 mg THC per container, taking effect around November 2026 (SC Daily Gazette). That federal limit would be stricter than the South Carolina Senate bill and would effectively wipe out most of the existing intoxicating-hemp market. The SC Senate bill reportedly includes a provision to adopt the federal standard. Note: the precise federal effective date is commonly cited as on or around November 12, 2026, but reporting on the exact day varies; the SC Daily Gazette account says "this November" without pinning the day. Treat the November 12, 2026 date as the widely referenced deadline but verify against the federal text.

The SC Republican Party state executive committee passed a resolution in March 2026 calling for a full statewide ban on all hemp-derived THC products, with state GOP Chairman Drew McKissick framing it as closing a "legal loophole" (SC Daily Gazette).

Psychedelics

All major psychedelics (psilocybin, LSD, DMT) are Schedule I controlled substances in South Carolina, with no medical or therapeutic exception (Psychedelic Passage, SC overview). No South Carolina decriminalization or therapeutic-access psychedelics bill was identified for the 2025-2026 session. National trackers cataloging more than 100 psychedelics bills across roughly 35 states in 2026 did not list South Carolina among active states (Psychedelic Alpha, March 2026 round-up). If a SC psychedelics bill exists it is unconfirmed; none surfaced in this research.

Broader drug policy

Decriminalization: South Carolina has not decriminalized marijuana. Three House bills would change that, all introduced in the House in early 2025 and referred to Judiciary: H. 3110 (decriminalize up to one ounce of marijuana or 10 grams of hashish, civil citation), H. 3804 (similar decriminalization with civil citation), and H. 3018 (legalize possession of up to one ounce for certain veterans with service-connected PTSD) (SC Legislature H. 3110; H. 3804; H. 3018). Per the Marijuana Policy Project and bill histories, none received a hearing in 2025 or 2026, and the General Assembly recessed May 14, 2026 without holding a hearing on any cannabis legislation (MPP South Carolina). H. 3110 is attributed to Rep. Chris Hart (D); H. 3804 lists Reps. Hart, King and Henderson-Myers per secondary reporting (confirm sponsor lists against the bill pages).

Harm reduction: Naloxone is broadly accessible through a statewide standing order / joint protocol, and intramuscular naloxone and associated syringes are legal under that protocol (Network for Public Health Law 50-state survey). Syringe services programs (SSPs) operate in practice through nonprofits such as Challenges Inc., which reports distributing more than 15,000 naloxone doses, 500-plus overdose reversals, and over 100,000 sterile syringes per year across several SC counties, but their statutory legal status has been described as "complicated" because SSPs are not clearly authorized in state law (Post and Courier; Challenges Inc.). A pending bill, S. 255 (Safer Syringe Program), would authorize community distributors to operate syringe programs and distribute supplies including fentanyl test strips (SC Legislature, S. 255). Status of S. 255 as of session end is unconfirmed; it does not appear to have been enacted.

Other 2026 substance laws: South Carolina enacted S. 751 regulating nitrous oxide ("whippets"), signed by Governor McMaster on May 18, 2026, barring recreational and flavored sales and sales to minors, with misdemeanor penalties (SC Daily Gazette, June 12, 2026; Fox Carolina). The exact bill number S. 751 is reported by secondary sources; treat as unconfirmed pending the bill page. A separate effort to add kratom to Schedule I and repeal the SC Kratom Consumer Protection Act stalled in the Senate in May 2026 and did not become law; existing law from the prior year bars kratom sales to anyone under 21 and requires labeling (SC Daily Gazette, May 7, 2026).

Sentencing and expungement: South Carolina has general expungement statutes, but there is no cannabis-specific automatic expungement or record-sealing mechanism, because no legalization or broad decriminalization has occurred. (See Equity and expungement.)

Political landscape

Governor: Henry McMaster (Republican) (Ballotpedia, 2026 SC legislative session). South Carolina is a Republican trifecta with veto-proof supermajorities in both chambers (Senate approximately 34 Republicans to 12 Democrats; House approximately 88 Republicans to 36 Democrats) (Ballotpedia).

Key committees: The Senate Committee on Medical Affairs is the gatekeeper for the medical cannabis bill (S. 53). The House Judiciary Committee handles decriminalization and the hemp bills. (Committee chair names not separately confirmed in this research; verify.)

Named reform champion: Sen. Tom Davis (R-Beaufort), the long-running lead sponsor of the Compassionate Care Act, is the clearest cannabis reform champion (Vicente LLP). On decriminalization, Rep. Chris Hart (D) is associated with H. 3110 per secondary reporting (confirm).

Named opponents: On hemp, Sen. Richard Cash (R-Piedmont) argued on the floor against the products; Sen. Billy Garrett (R-Greenwood) pushed for a complete ban, citing his son's death; SC GOP Chairman Drew McKissick and the state party executive committee called for a full statewide ban on hemp-derived THC (SC Daily Gazette, March 20, 2026). Sen. Michael Johnson (R-Tega Cay) shepherded the hemp compromise, and Senate Majority Leader Shane Massey (R) backed regulation with a driving-impairment threshold (SC Daily Gazette). The South Carolina House leadership has been the persistent obstacle to medical cannabis, though no single named House opponent is confirmed here.

Ballot initiatives

South Carolina does not have a statewide citizen initiative or popular referendum process. Voters cannot place a cannabis or drug-policy measure on the ballot by petition; all changes must go through the General Assembly. There are accordingly no pending citizen-initiated drug-policy ballot measures. (General background: South Carolina is consistently listed among the states without statewide initiative/referendum.)

Equity and expungement

Because South Carolina has neither a legal cannabis market nor broad decriminalization, there are no social-equity licensing provisions to report. The Compassionate Care Act (S. 53), if it ever passed, is a medical-only, tightly limited license model and does not include a social-equity program of the kind seen in adult-use states; it is structured around a capped number of cultivators, processors and pharmacies overseen by health regulators (Vicente LLP).

On records: South Carolina has general expungement statutes for certain offenses, but there is no cannabis-specific automatic expungement or record-sealing program, and the pending decriminalization bills (H. 3110, H. 3804) did not advance. The practical effect is that people with prior marijuana possession convictions remain reliant on the standard, petition-based expungement process where eligible, with no mass or automatic relief tied to drug-policy reform. (No SC-specific automatic-expungement statute for cannabis was found; treat the absence as the finding.)

Market and barriers

There is no legal adult-use or medical cannabis market, so there are no cannabis tax rates, license fees, or licensee counts to report.

For the proposed hemp beverage regime under H. 4759 (not yet confirmed enacted), the bill text sets specific numbers (SC Legislature, H. 4759): - Biennial license taxes: manufacturer $50,000; wholesaler $20,000; retail dealer $1,200. - Application filing fee: $100 per location, nonrefundable. - Hemp beverages taxed at the same rate and manner as alcoholic liquors. - Product cap (House/bill base): 5 mg THC per 12-ounce beverage; Senate amendment allowed liquor stores to sell beverages and gummies up to 10 mg THC per serving, other stores limited to 5 mg beverages behind the counter (SC Daily Gazette). - Retail hemp beverage dealers must also hold a retail liquor store license, a significant barrier that channels the market through existing liquor retailers.

These figures apply only if the hemp bill becomes law in this form; the proposed three-tier (manufacturer / wholesaler / retailer) structure mirrors the state alcohol system.

Enclosure read

South Carolina is heavily fenced. The state bars adult-use and medical cannabis entirely, blocks citizen ballot initiatives, and in 2026 tried but failed to fence in the one open cannabinoid market it had, intoxicating hemp: H. 4759 would have routed legal sales through licensed liquor stores, imposed five-figure license taxes, and required a retail liquor license to sell hemp beverages, but the House did not concur, so those products remain legal for adults for now. That proposed structure would have fenced out the independent vape shops and CBD retailers that built the hemp-THC market since 2018 and consolidated whatever legal market survived into the hands of established, capitalized liquor-license holders and a small set of licensed manufacturers and wholesalers. The looming federal 0.4 mg per container limit (around November 2026) would fence the market still further, potentially eliminating most products regardless of state action. Meanwhile, harm-reduction infrastructure (syringe services) operates in a legal gray zone rather than with clear statutory protection, and decriminalization bills cannot even get a hearing. The only modest counterweights are broad naloxone access and the persistence of the Senate-backed medical bill, neither of which has produced a functioning legal market. Score: 5/5 (corrected July 18, 2026; an earlier version of this brief scored South Carolina 4). Under the July 2026 re-score, a state with no legal cannabis market scores as fully enclosed, and the hemp shelf presence does not lower the score: it is a lane already being the target of a 2026 narrowing effort (H. 4759) that failed, leaving it legal for all adults for now, with the federal cliff still scheduled to clear most of what remains. Naloxone access is a real strength and stays recorded above, but it is not access to the plant commons this score measures.

What to watch next

  • Hemp bill H. 4759 failed when the House did not concur in the Senate amendments before the regular session ended May 14, 2026, so it dies with the 126th General Assembly; watch for a renewed hemp-restriction effort in 2027 (SC Legislature, H. 4759).
  • Federal hemp deadline: the new federal hemp THC limit (no more than 0.4 mg per container) is set to take effect around November 2026 (the widely cited November 12, 2026 date should be verified against the federal text); it would override or tighten state rules.
  • Next legislative session: the South Carolina General Assembly convenes the new (127th) General Assembly in January 2027 (regular sessions begin the second Tuesday of January). All unpassed 2025-2026 bills, including S. 53 and the decriminalization bills, must be refiled.
  • 2026 elections: South Carolina holds statewide elections in November 2026 (Governor McMaster's seat and legislative seats), which could reshape the medical-cannabis and hemp debates (Ballotpedia, 2026 SC gubernatorial election).
  • Kratom: expect a renewed scheduling/ban effort in 2027 after the 2026 bill stalled (SC Daily Gazette, May 7, 2026).
  • Syringe services: watch whether S. 255 or a successor is refiled to give SSPs clear statutory authorization.

Regulators

  • South Carolina Department of Agriculture (SCDA): regulates the hemp farming program and would define "consumable hemp product" and "intoxicating hemp product" under H. 4759 (H. 4759 text).
  • South Carolina Department of Revenue (SCDOR): would administer hemp beverage licensing and taxation under H. 4759.
  • South Carolina Law Enforcement Division (SLED): enforcement of hemp/THC and controlled-substance laws; named enforcer in H. 4759 and the nitrous oxide law.
  • South Carolina Department of Public Health (DPH) and the South Carolina Board of Pharmacy: would oversee the medical cannabis program under S. 53 if enacted (Vicente LLP).
  • Department of Alcohol and Other Drug Abuse Services (DAODAS): state authority on substance use treatment, overdose response and naloxone distribution (agency role general background).

Federal exposure (2026)

South Carolina sits almost entirely outside the parts of the 2026 federal shift that help cannabis operators, and squarely inside the parts that hurt hemp and harm reduction.

Rescheduling and 280E. By default cannabis remains Schedule I under federal law. In April 2026 a DOJ/DEA order moved only FDA-approved cannabis drugs and state-licensed medical cannabis to Schedule III; recreational cannabis stays Schedule I, and a broader DEA hearing opened June 29, 2026 (and may slip to 2027) (DEA scheduling docket, unconfirmed exact citation). The practical effect for South Carolina is zero. The 280E relief that comes with Schedule III, ending the federal tax code's denial of ordinary business deductions to sellers of Schedule I and II substances, only matters to businesses that have legal cannabis revenue to deduct against. South Carolina has no legal medical or adult-use cannabis market, so there are no licensed operators here to benefit, no taxable cannabis income, and nothing for the carve-out to relieve. The federal medical carve-out does nothing for a prohibition state: it lowers the federal tax burden on operators in the roughly three dozen states that already license medical cannabis, while a non-program state like South Carolina gets none of the upside and watches the gap between itself and program states widen. If the Compassionate Care Act (S. 53) ever passed, a state-licensed medical program could in principle align with the Schedule III medical category, but that is contingent on a state law that has never cleared the House. Schedule III does not legalize anything, does not authorize interstate commerce, and does not shield state-licensed businesses from the remaining federal controlled-substance framework, so even a future SC medical program would not gain a federal commercial green light.

The November 12, 2026 hemp cliff. This is South Carolina's single largest federal exposure. The FY2026 agriculture appropriations law (Section 781, associated with Rep. Andy Harris, R-MD) narrows the federal definition of legal hemp to a total-THC standard of roughly 0.4 mg THC per container, which recriminalizes an estimated 90 to 95 percent of intoxicating hemp products, effective November 12, 2026 (federal FY2026 ag appropriations, Sec. 781, exact citation unconfirmed). A proposed delay (H.R. 7010, unconfirmed) was not enacted, and the 2026 Farm Bill (H.R. 7567, unconfirmed) keeps the ban. This federal limit is stricter than anything in the South Carolina Senate-passed version of H. 4759, which would have kept low-dose hemp products legal (beverages and gummies up to 10 mg THC per serving in liquor stores, 12-ounce beverages capped at 5 mg THC elsewhere) (SC Daily Gazette, March 20, 2026). The two regimes interact in a way that is unusually decisive here: South Carolina's gas-station and vape-shop hemp-THC market exists almost entirely because of the 2018 federal loophole, not because of any affirmative state authorization, so when the federal floor moves to total-THC at roughly 0.4 mg per container, the products lose their federal legality regardless of what the General Assembly does. The state Senate bill reportedly contemplated adopting the federal standard, which would make state and federal law point the same direction. Practical effect: most intoxicating-hemp products on South Carolina shelves are slated to become federally non-compliant on November 12, 2026, and because the state never built an independent legal basis for them, there is little state-law cushion to fall back on. The exact effective day is widely cited as November 12, 2026; verify against the enrolled federal text (SC Legislature, H. 4759).

Banking. Not applicable in any operative sense. The SAFER Banking Act has stalled in Congress, but even if it passed it would protect financial services to state-legal cannabis businesses, of which South Carolina has none. There is no legal cannabis market here for banks to serve or refuse, so the banking question is moot until and unless the state licenses a program.

Psychedelics. South Carolina has no state psychedelics program and filed no therapeutic-access or decriminalization bill in 2025-2026 (see Psychedelics). Psilocybin, MDMA and ibogaine all remain Schedule I federally. The April 18, 2026 federal executive order plus FDA priority vouchers are designed to fast-track FDA review, but no psychedelic has been approved, and there is no approval yet to import into state law. Any near-term South Carolina access route runs through the federal FDA pathway, not through state legislation; for now there is no state lever and no federal product to attach one to.

Fentanyl. The HALT Fentanyl Act (July 17, 2025) permanently placed fentanyl-related substances in Schedule I at the federal level. This aligns with South Carolina's existing prohibitionist posture and creates no conflict; it reinforces the state's controlled-substance enforcement and adds nothing the state would resist.

Harm reduction. This is the second significant federal exposure for South Carolina. The state's harm-reduction picture is split: naloxone is broadly available through a statewide standing order, and that support is unaffected because federal policy still backs naloxone. But on April 24, 2026 SAMHSA guidance barred the use of federal funds for fentanyl test strips, clean syringes, and sterile water (SAMHSA harm-reduction funding guidance, April 24, 2026, exact citation unconfirmed). South Carolina's syringe services programs already operate in a legal gray zone, run by nonprofits such as Challenges Inc. without clear statutory authorization and with a pending but unenacted bill, S. 255, that would authorize them (Post and Courier; SC Legislature, S. 255). Those programs are doubly exposed: they lack a clear state-law footing, and now the federal funding stream for the core consumables they distribute (test strips, clean syringes, sterile water) is cut off. Naloxone distribution should continue, but the syringe and test-strip side of South Carolina harm reduction now depends on non-federal money in a state that has not affirmatively legalized the activity.

Patient access and rights

This section covers what South Carolina law does and does not protect for a medical cannabis patient: use inside a hospital, and the broader rights that follow a patient into work, housing, parenting, an organ transplant list, and school. It is information, not legal advice, and it reflects the law as of July 2026.

South Carolina has no operational medical cannabis program. The only cannabis measure on its books is a 1980 therapeutic-research statute that was never implemented and gives no patient access. Efforts to create a real program have repeatedly stalled.

Hospital access (Ryan's Law): South Carolina has no hospital-access law. No statute requires a hospital or similar facility to let a patient use medical cannabis on site, so the decision is left to each facility's own policy. Seven states have now enacted a Ryan's Law protection (California in 2021, and Colorado, Delaware, Louisiana, Oregon, Virginia, and Washington in 2026), with Pennsylvania's bill pending; South Carolina is not among them.

Broader protections: here the absence is the finding. A review of South Carolina law found no statutory protection for a medical cannabis patient in any of the areas other states cover: not employment, not housing, not a custody or visitation dispute, not placement on an organ transplant list, and not school enrollment, and there is no general medical-care protection. In these situations the patient has no enforceable shield; the protection does not exist in state law today.

Out-of-state patients: South Carolina has no program and does not recognize other states' medical cannabis cards.

The federal picture: the April 2026 federal move of state-licensed medical cannabis to Schedule III did not change any of this. Schedule III does not make dispensary cannabis a lawful prescription medicine, and it creates no hospital-use right and no employment, housing, custody, transplant, or school protection; only state law can create those, and South Carolina has not.

What to watch: the Compassionate Care Act (Senate Bill 53) is stuck in the Senate Medical Affairs Committee and has passed neither chamber.

Sources: South Carolina has no operational program; on the pending measure, the Compassionate Care Act, Senate Bill 53.

Related reading from Drug Policy Watch: the Federal Drug Policy Brief, the Schedule III rescheduling explainer, and the 50-State Matrix.

Analysis: the enclosure read in depth

Who is fenced out in South Carolina. The state is one of the most thoroughly enclosed in the country, and the fencing is structural rather than incidental. First, there is no popular escape valve: South Carolina has no statewide citizen initiative or referendum, so voters cannot place a medical-cannabis, decriminalization, or psychedelics question on the ballot the way reform passed in many western states. Every change must move through the General Assembly. Second, the Assembly is a Republican veto-proof trifecta (Governor McMaster plus supermajorities of roughly 34-12 in the Senate and 88-36 in the House), so reform cannot pass over conservative objection and faces no electoral-map pressure to compromise. Third, the one persistent reform vehicle, the Compassionate Care Act (S. 53, Sen. Tom Davis, R-Beaufort), has cleared the Senate in prior sessions but has never cleared the House, and stalled again in committee in 2025-2026, dying at sine die on May 14, 2026 (SC Legislature, S. 53). The result is that ordinary South Carolinians, patients, would-be small cannabis operators, and the independent vape and CBD retailers who built the hemp-THC market, are all fenced out: patients have no legal medical access, small operators have no market to enter, and the hemp retailers are about to be fenced out of the only cannabinoid market the state allowed.

State-plus-federal interaction. South Carolina is unusual because the state and federal vectors point the same direction and compound each other. On hemp, the state was already moving in 2026 to route the surviving market through licensed liquor stores with five-figure license taxes (manufacturer $50,000, wholesaler $20,000, retail dealer $1,200) and a required retail liquor license, which by itself fences out the gas-station and vape-shop incumbents and consolidates the market into established liquor-license holders. The November 12, 2026 federal total-THC limit then threatens to eliminate most of the product category outright, so even the consolidated, liquor-store-channeled market may have little legal inventory left to sell. On cannabis, the federal Schedule III medical carve-out and its 280E relief reward the states that built programs and bypass South Carolina entirely, widening the gap. On harm reduction, the SAMHSA funding cut lands on programs that already lack state authorization, squeezing them from both the state and federal side. In each lane, federal enclosure reinforces state enclosure rather than offsetting it.

What to watch. Whether any successor to S. 53 is refiled and whether the House ever grants a hearing in the 127th General Assembly that convenes January 2027; whether the reconciled hemp bill (H. 4759) cleared both chambers before sine die (unconfirmed) and how the state conforms to the federal total-THC standard; the November 12, 2026 federal hemp effective date and any late delay; whether S. 255 or a successor gives syringe programs statutory cover as federal funding for their supplies disappears; and the November 2026 statewide elections, which could shift the House math that has blocked medical cannabis for years.

Absence of commons counter-moves. What stands out in South Carolina is the near-total absence of countervailing, commons-oriented policy. There is no home-cultivation right, even in the proposed medical bill, which bans home grow; no social-equity licensing, because there is no market; no automatic or cannabis-specific expungement, leaving prior-conviction relief to the standard petition process; no decriminalization (the three filed bills never got a hearing); no statutory protection for syringe services; and no citizen-initiative path to force any of these from below. The only genuine open commons is broad naloxone access, and even adjacent harm-reduction supplies are now losing federal funding. There is essentially nothing on the other side of the ledger pushing back against enclosure.

Justifying the enclosure score. The score is 5/5, corrected July 18, 2026; an earlier version of this brief held it at 4. South Carolina has the full enclosure toolkit working in one direction: total cannabis prohibition, no ballot initiative, a veto-proof trifecta, a medical bill that cannot pass, decriminalization bills that cannot get a hearing, a 2026 effort to narrow the hemp regime to capitalized liquor-license holders (H. 4759) that failed at sine die, leaving hemp legal for all adults for now but still exposed to the federal total-THC cliff, harm reduction in a legal gray zone now losing federal money, and no commons counter-moves of consequence. The earlier 4 rested on two openings: intoxicating-hemp products still legally on shelves as of mid-2026, and broad naloxone access. The July 2026 re-score corrected that reading. The hemp shelf presence is not an opening in the fence but a lane already being handed to capitalized liquor-license holders, with the federal cliff scheduled to clear most of it on November 12, 2026, and naloxone access, while real and recorded above, is not access to the plant commons this score measures. A state with no legal cannabis market of any kind, no ballot valve, and its one informal lane being consolidated and then closed is fully fenced today.

Active legislation (2026)

This list is not exhaustive. For the full long tail, use the live trackers: LegiScan South Carolina, the SC Legislature bill search. The 2026 regular session adjourned sine die May 14, 2026; bills not passed die with the 126th General Assembly and would need refiling in 2027.

Beyond the live tracker

These measures are not in the live bill list below: some are not bills (executive orders, rules, referendums, or budgets), and some are proposals or prior-session measures the live tracker does not currently carry.

  • S. 751 (number unconfirmed) Nitrous Oxide Regulation ("whippets") (Enacted; signed by Gov. McMaster May 18, 2026)
Bill Title/Topic Chamber Status Sponsor(s)
S. 53 Compassionate Care Act (medical cannabis) Senate Pending in Senate Medical Affairs; did not advance to a House vote; died at sine die Sen. Tom Davis (R)
H. 4759 Intoxicating Hemp Beverages (ban most products, alcohol-style licensing for low-dose beverages) House (originated); Senate amended Senate passed an amended version 35-4 on March 20, 2026; returned to the House, which did not concur before sine die, so H. 4759 failed and hemp THC products remain legal for adults in South Carolina. (source) Rep. W. Newton (R) plus ~40 GOP co-sponsors
H. 3110 Marijuana decriminalization (up to 1 oz, civil citation) House Referred to Judiciary; no hearing in 2025-2026 Rep. Chris Hart (D) (per secondary reporting; confirm)
H. 3804 Marijuana decriminalization (civil citation) House Referred to Judiciary; no hearing Reps. Hart, King, Henderson-Myers (per secondary reporting; confirm)
H. 3018 Marijuana decriminalization for veterans with service-connected PTSD House Referred to committee; no hearing Unconfirmed (verify on bill page)
S. 255 Safer Syringe Program (authorize SSPs, fentanyl test strips) Senate Pending; not enacted Unconfirmed (verify on bill page)
S. 751 (number unconfirmed) Nitrous Oxide Regulation ("whippets") Senate Enacted; signed by Gov. McMaster May 18, 2026 Unconfirmed
H. 4636 / H. 4641 / H. 4030 / S. 221 Kratom (scheduling / Consumer Protection Act) Both Schedule I ban effort stalled in Senate May 2026; not enacted Unconfirmed (multiple bills; verify)
H. 4758 / H. 3924 / H. 3935 Companion hemp bills (hemp beverage ban, hemp-derived ingestibles/consumables) House Companion/similar to H. 4759; statuses vary Unconfirmed

Note: companion bill numbers for H. 4759 (3924, 3935, 4758) are listed on the official bill page (SC Legislature, H. 4759). Sponsor and exact-status fields marked "unconfirmed" should be checked against the official bill pages before publication.

Support this work

This work is free and reader-funded. No paywalls, no ads. This brief is independent and fully sourced, and reader contributions are what keep the 50-state coverage current and answerable to readers, not advertisers or owners.

If it helped you, please chip in $5 to keep it going. Recurring support helps most; about $25 funds a full refresh of a state brief like this one.

Contribute $5 on Ko-fi Become a member

← Back to all 50 states and federal briefs

A planning snapshot for 2026, not legal advice. Policy moves quickly; confirm any single detail against the cited sources before acting on it. Sponsor names are given where confirmable and marked unconfirmed otherwise.

About the author. Jessica Mantonya is the founder of Drug Policy Watch and Hold in Common. She also advises operators, advocates, and funders on regulatory strategy and anti-enclosure positioning. Work with her →

Sources